With the CBSE Class 12 Math exam on March 9, 2026, approaching, students are urged to focus on conceptual clarity and smart revision. Teachers emphasize mastering calculus, core algebra, vectors, and ...

Fidelity Mid-Cap Stock Fund grew 5.38 percent as it capitalized on the early innings of artificial intelligence. See how ...

Alpha Technology Group Limited (ATGL) remains a Strong Sell due to deteriorating financials, poor competitive positioning, ...

Principals largely said they want to get better at helping their teachers succeed, improving their own work-life balance, and ...

Your continued support has helped steer Allarity Therapeutics through a period of meaningful transformation and disciplined ...

TAMPA, Fla. and LONDON, Dec. 30, 2025 (GLOBE NEWSWIRE) -- Akari Therapeutics, Plc (Nasdaq: AKTX), an oncology biotechnology company developing antibody drug conjugates (ADCs) with novel payloads today ...

This move represented a sharp increase in price on volume nearly 3x the average daily trading volume, indicating robust ...

Domestic players must adapt agilely and effectively to a noticeable shift in segment-specific consumer behavior amid weaker ...

Glow up or grow up? Times columnists Anita Chabria and Mark Z. Barabak look back and assess whether 2025 was good for America ...

Palmolive’s shares (currently trading at $79.74) have posted a disappointing 12.3% loss, well below the S&P 500’s 11.7% gain. This might have investors contemplating their next move.

Adding the capabilities builds on momentum to further expand technology to deliver safer, more intelligent, and more ...

PALI-2108 is the first and only PDE4 inhibitor in development targeting the terminal ileum and colon for treatment of ulcerative colitis (UC) and fibrostenotic Crohn’s disease (FSCD) to address ...